The Silencing of CCND2 by Promoter Aberrant Methylation in Renal Cell Cancer and Analysis of the Correlation between CCND2 Methylation Status and Clinical Features

Hypermethylation of the 16q23.1 Tumor Suppressor Gene ADAMTS18 in Clear Cell Renal Cell Carcinoma

(2015) Ben Xu et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

DLEC1, a 3p tumor suppressor, represses NF-κB signaling and is methylated in prostate cancer

(2015) Lian Zhang et al.   JOURNAL OF MOLECULAR MEDICINE-JMM

Interferon regulatory factor 8 functions as a tumor suppressor in renal cell carcinoma and its promoter methylation is associated with patient poor prognosis

(2014) Qian Zhang et al.   CANCER LETTERS

The prognostic value of cyclin D1 in renal cell carcinoma

(2013) M. S. Lima et al.   INTERNATIONAL UROLOGY AND NEPHROLOGY

D-type Cyclins are important downstream effectors of cytokine signaling that regulate the proliferation of normal and neoplastic mammary epithelial cells

(2013) Qian Zhang et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Promoter de-methylation of cyclin D2 by sulforaphane in prostate cancer cells

(2011) Anna Hsu et al.   Clinical Epigenetics

Aberrant Promoter Methylation of DLEC1, a Critical 3p22 Tumor Suppressor for Renal Cell Carcinoma, is Associated With More Advanced Tumor Stage

(2010) Qian Zhang et al.   JOURNAL OF UROLOGY

Epigenetics in Cancer

(2008) Manel Esteller   NEW ENGLAND JOURNAL OF MEDICINE